ACCELERANT HOLDINGS-CL A (ARX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ARX • KYG008941083

11.42 USD
+0.03 (+0.26%)
At close: Feb 10, 2026
11.42 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ARX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 149 industry peers in the Insurance industry. While ARX seems to be doing ok healthwise, there are quite some concerns on its profitability. ARX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ARX had negative earnings in the past year.
  • In the past year ARX had a positive cash flow from operations.
ARX Yearly Net Income VS EBIT VS OCF VS FCFARX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • The Return On Assets of ARX (-17.86%) is worse than 93.96% of its industry peers.
  • ARX's Return On Equity of -207.57% is on the low side compared to the rest of the industry. ARX is outperformed by 93.29% of its industry peers.
  • The Return On Invested Capital of ARX (0.71%) is worse than 64.43% of its industry peers.
Industry RankSector Rank
ROA -17.86%
ROE -207.57%
ROIC 0.71%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARX Yearly ROA, ROE, ROICARX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -10 -20

1.3 Margins

  • ARX has a Operating Margin of 9.41%. This is in the lower half of the industry: ARX underperforms 61.74% of its industry peers.
  • ARX does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 9.41%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARX Yearly Profit, Operating, Gross MarginsARX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10 -20 -30 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARX is destroying value.
  • ARX has about the same amout of shares outstanding than it did 1 year ago.
  • ARX has a better debt/assets ratio than last year.
ARX Yearly Shares OutstandingARX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
ARX Yearly Total Debt VS Total AssetsARX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.04, we must say that ARX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ARX (0.04) is better than 68.46% of its industry peers.
  • The Debt to FCF ratio of ARX is 0.21, which is an excellent value as it means it would take ARX, only 0.21 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ARX (0.21) is better than 90.60% of its industry peers.
  • ARX has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • ARX has a Debt to Equity ratio of 0.18. This is in the better half of the industry: ARX outperforms 71.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.21
Altman-Z 0.04
ROIC/WACC0.08
WACC8.76%
ARX Yearly LT Debt VS Equity VS FCFARX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 0.17 indicates that ARX may have some problems paying its short term obligations.
  • The Current ratio of ARX (0.17) is better than 68.46% of its industry peers.
  • A Quick Ratio of 0.17 indicates that ARX may have some problems paying its short term obligations.
  • ARX has a Quick ratio of 0.17. This is in the better half of the industry: ARX outperforms 68.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
ARX Yearly Current Assets VS Current LiabilitesARX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ARX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 155.73%, which is quite impressive.
  • The Revenue has grown by 78.63% in the past year. This is a very strong growth!
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23389%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 65.07% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ARX will show a very strong growth in Revenue. The Revenue will grow by 26.27% on average per year.
EPS Next Y541.38%
EPS Next 2Y129.79%
EPS Next 3Y88.74%
EPS Next 5Y65.07%
Revenue Next Year55.46%
Revenue Next 2Y32.85%
Revenue Next 3Y26.27%
Revenue Next 5YN/A

3.3 Evolution

ARX Yearly Revenue VS EstimatesARX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ARX Yearly EPS VS EstimatesARX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 17.50, ARX is valued on the expensive side.
  • ARX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ARX is more expensive than 66.44% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.97. ARX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 17.5
ARX Price Earnings VS Forward Price EarningsARX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ARX.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARX indicates a somewhat cheap valuation: ARX is cheaper than 75.84% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.33
EV/EBITDA 8.71
ARX Per share dataARX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

  • ARX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ARX's earnings are expected to grow with 88.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y129.79%
EPS Next 3Y88.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ARX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACCELERANT HOLDINGS-CL A

NYSE:ARX (2/10/2026, 8:04:00 PM)

After market: 11.42 0 (0%)

11.42

+0.03 (+0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-09
Earnings (Next)N/A
Inst Owners46.97%
Inst Owner Change0%
Ins Owners49.23%
Ins Owner Change-0.54%
Market Cap2.53B
Revenue(TTM)802.70M
Net Income(TTM)-1.40B
Analysts78.57
Price Target21.48 (88.09%)
Short Float %3.25%
Short Ratio1.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.16%
Min EPS beat(2)6.63%
Max EPS beat(2)75.69%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)3.07%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.88%
PT rev (3m)-6.94%
EPS NQ rev (1m)-1.4%
EPS NQ rev (3m)3.31%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)27.88%
Revenue NQ rev (1m)-2.56%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-1.64%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.5
P/S 3.16
P/FCF 4.33
P/OCF 4.05
P/B 3.75
P/tB 5.46
EV/EBITDA 8.71
EPS(TTM)-6.82
EYN/A
EPS(NY)0.65
Fwd EY5.72%
FCF(TTM)2.64
FCFY23.12%
OCF(TTM)2.82
OCFY24.67%
SpS3.62
BVpS3.05
TBVpS2.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.86%
ROE -207.57%
ROCE 0.99%
ROIC 0.71%
ROICexc 0.91%
ROICexgc 3.15%
OM 9.41%
PM (TTM) N/A
GM N/A
FCFM 72.97%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.21
Debt/EBITDA 1.09
Cap/Depr 108.59%
Cap/Sales 4.88%
Interest Coverage 7.26
Cash Conversion 559.95%
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z 0.04
F-Score5
WACC8.76%
ROIC/WACC0.08
Cap/Depr(3y)271.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23389%
EPS Next Y541.38%
EPS Next 2Y129.79%
EPS Next 3Y88.74%
EPS Next 5Y65.07%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.49%
Revenue Next Year55.46%
Revenue Next 2Y32.85%
Revenue Next 3Y26.27%
Revenue Next 5YN/A
EBIT growth 1Y245.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year681.59%
EBIT Next 3Y115.82%
EBIT Next 5Y72.97%
FCF growth 1Y191.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y170.93%
OCF growth 3YN/A
OCF growth 5YN/A

ACCELERANT HOLDINGS-CL A / ARX FAQ

What is the ChartMill fundamental rating of ACCELERANT HOLDINGS-CL A (ARX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ARX.


Can you provide the valuation status for ACCELERANT HOLDINGS-CL A?

ChartMill assigns a valuation rating of 4 / 10 to ACCELERANT HOLDINGS-CL A (ARX). This can be considered as Fairly Valued.


What is the profitability of ARX stock?

ACCELERANT HOLDINGS-CL A (ARX) has a profitability rating of 0 / 10.


What is the earnings growth outlook for ACCELERANT HOLDINGS-CL A?

The Earnings per Share (EPS) of ACCELERANT HOLDINGS-CL A (ARX) is expected to grow by 541.38% in the next year.